Upcoming Symposium and More
2023 SBI Breast Imaging Symposium
DBI’s Dr. Wendie Berg, Robin Seitzman, PhD, MPH, and JoAnn Pushkin will be in attendance. Please stop by booth #326 to learn more about DBI educational tools or to discuss the FDA dense breast reporting rule or the federal Find it Early Act.
The announcement and implications of the new FDA “dense breast” reporting rule continue to attract much press interest:
- A conversation with DBI’s Chief Scientific Advisor Dr. Wendie Berg, “The FDA’s rule change requiring providers to inform women about breast density could lead to a flurry of questions” was just published in The Conversation. The comprehensive round up of considerations includes information on what the new FDA ruling entails, how it might affect patient response to mammogram results, a list of risk factors that would make a woman “high risk,” and insurance issues for supplemental screening.
- Dr Wendie Berg discusses improving early detection of breast cancer by implementing current guidelines and technologies with EUSOBI’s Prof. Matthias Dietzel in a YouTube video available HERE.